CompoAtlas

Thyroformula

Thyroformula, licence 80072589: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
BNI Supplements Inc.
NPN or DIN-HM
80072589
Status
Active licence
Licence date
16 September 2016
Revision date
7 February 2017
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
L-Tyrosine

Source : L-Tyrosine

150.0 milligrammeNot calculated
Sélénium

Source : Sélénométhionine

25.0 microgrammesNot calculated
Zinc

Source : Diglycinate de zinc

5.0 milligramme10,000 µg
Iode

Source : Iodure de potassium

150.0 microgrammesNot calculated
Plectranthus barbatus

Source : Racine

Potency : 10.0 % Forskoline

250.0 milligrammeNot calculated
Withania somnifera

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 12.0:1.0

Dry plant equivalent : 3000 milligramme

250.0 milligrammeNot calculated

Non-medicinal ingredients

farine de riz, Hypromellose, Gélatine, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
AdultesNot specified2.0 Capsule1.0 Tous les jours

Uses authorised in Canada

L'Iode et le sélénium aident à maintenir la production normale des hormones thyroïdiennes. Le zinc aide à la formation du tissu conjonctif, aide au maintien des fonctions immunitaires, aide au métabolisme de l¿énergie et à la formation des tissus, aide à maintenir la synthèse normale de l¿ADN et aide à maintenir le métabolisme acide-base normal. Source d¿antioxydant qui aide à combattre les dommages cellulaires causés par les radicaux libres. L'Ashwagandha est utilisé traditionnellement en Ayurveda comme Rasayana (tonique régénérateur) et pour l¿amélioration de la mémoire.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80072589

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2017. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2017. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line